News

CEM Corporation Unveils Innovative Peptide Purification System

CEM Corporation Unveils Innovative Peptide Purification System

CEM Corporation Launches Prodigy 2.0 Peptide Purification System

CEM Corporation has announced an exciting new addition to their product lineup: the Prodigy 2.0. This preparative HPLC (High-Performance Liquid Chromatography) system is tailored specifically for the purification of synthetic peptides, making a significant stride in the laboratory instrumentation field.

Advancements in Green Technology

The Prodigy 2.0 is not just any purification system. It symbolizes a paradigm shift towards more sustainable practices in peptide purification. It achieves this by significantly enhancing recoveries while completely eliminating the need for acetonitrile, a common solvent in traditional methods, and replacing it with ethanol. This groundbreaking change is facilitated by a high-efficiency heating system that efficiently heats both the column and mobile phase, overcoming challenges faced due to ethanol's higher viscosity.

Benefits of Elevated Temperature Operation

Operating at elevated temperatures is a game-changer, as it greatly improves both the peak shape during purification and the solubility of peptides. When run at 60 °C, recoveries can increase by an impressive 50% compared to methods that operate at room temperature. This means more effective and productive workflows for laboratories focused on peptide synthesis.

Research and Insights

Recent studies underscore the advantages of the Prodigy 2.0 system. A paper titled "Greening Peptide Purification Through Replacement of Acetonitrile with Ethanol" is set to be presented at the renowned 29th American Peptide Symposium. This presentation will highlight the system's innovative approach to peptide purification and the positive impacts of switching to more environmentally friendly solvents.

Innovative Features of Prodigy 2.0

The Prodigy 2.0 is packed with advanced features designed to enhance user experience and efficiency. Standard inclusions are a 5-position autosampler, a high-capacity fraction collector, and a sophisticated focused gradient calculator. An exceptional automated sample injection system enables users to inject virtually unlimited volumes of samples, making it particularly useful for low-solubility peptides.

Industry Impact and Significance

According to Jonathan M. Collins, the Vice President of Business Development at CEM, "Peptide purification is a key challenge in the production of synthetic peptides. We believe the Prodigy 2.0 offers unique and meaningful benefits that will address key needs of the market for more efficient and greener peptide production." This aligns with the growing demand in the pharmaceutical and biotech sectors for robust, environmentally conscious solutions in laboratory settings.

About CEM Corporation

CEM Corporation is a prominent private company that operates on a global scale, providing cutting-edge laboratory instrumentation solutions. Based in Matthews, North Carolina, CEM has carved out a leadership position in the industry with subsidiaries in several countries, including France, Germany, India, Italy, Japan, Singapore, and the United Kingdom. The company specializes in the design and manufacture of systems for peptide synthesis, analytical testing, and processing across a multitude of industries such as pharmaceuticals, biotech, chemical, and food processing. CEM's commitment to innovation and excellence positions it as a critical player in advancing laboratory technologies.

Frequently Asked Questions

What is the Prodigy 2.0?

The Prodigy 2.0 is a new preparative HPLC system from CEM Corporation designed for the purification of synthetic peptides.

How does the Prodigy 2.0 improve efficiency?

It increases recovery rates by operating at higher temperatures and replacing acetonitrile with ethanol, leading to better peak shapes and peptide solubility.

What presentation will feature the Prodigy 2.0?

A research paper titled "Greening Peptide Purification Through Replacement of Acetonitrile with Ethanol" will be presented at a significant American Peptide Symposium.

What features does the Prodigy 2.0 have?

Features include a 5-position autosampler, a high-capacity fraction collector, and an automated sample injection system that accommodates large volumes.

What is CEM Corporation's area of expertise?

CEM specializes in laboratory instrumentation and solutions for peptide synthesis, analytical testing, and various processing applications across different industries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 37

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 40

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 52

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 46

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 35

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

NORBIT Secures Significant NOK 120M Defence Order

Updated Category News Views 288

NORBIT Secures Significant NOK 120 Million Defence Order NORBIT has recently made an exciting announcement regarding a significant contract within its segment PIR. The company has been awarded a manufacturing order valued at NOK 120 million from a European client specializing in defence and security. This order is poised for delivery in late 2025 and early 2026, marking a...

Continue Reading
Shareholder Concerns Over BCO, SEM, NATL Transactions

Updated Category News Views 12

Is There Smoke Without Fire in Recent Company Mergers? Well, here we go again. It seems every time deals like these pop up, questions start flying about fairness and insider scoops. The big fish here? The Brink's Company (NYSE:BCO), Select Medical Holdings Corporation (NYSE:SEM), and NCR Atleos Corporation (NYSE:NATL). Halper Sadeh LLC, the investor rights firm, is on a...

Continue Reading
TG Therapeutics Director’s Recent Stock Sale Raises Questions

Updated Category News Views 120

Significant Insider Transaction at TG Therapeutics Recently, an important transaction came to light involving Yann Echelard, Director at TG Therapeutics (NASDAQ:TGTX). The details were revealed through the latest SEC filing. On a given date, Echelard sold 5,000 shares, raising a total of $162,850. Such insider trading can often prompt discussions regarding the company’s...

Continue Reading
Innovative Leadership in Facilities Management Revolutionized

Updated Category News Views 214

MasonMade Ventures Launches to Revamp Facilities Management Serial Entrepreneurs Aim to Disrupt the FM Industry through Innovative Software Solutions and Expert Trades MasonMade Ventures, established by visionary entrepreneurs Joseph Scaretta and Moses Carrasco, is set to change the face of facilities management. This operational holding company focuses on investing in...

Continue Reading
Kyverna Therapeutics Engages Investors at Upcoming Events

Updated Category News Views 136

Kyverna Therapeutics' Upcoming Investor Conferences Kyverna Therapeutics, Inc. (NASDAQ: KYTX), a pioneering clinical-stage biopharmaceutical company committed to innovative cell therapies for autoimmune diseases, is slated to present at a series of significant investor conferences this September. Warner Biddle, the Chief Executive Officer of Kyverna, will be the...

Continue Reading